CANAVERAL

Owners

Goods & Services

Biotechnology, medical and scientific research, and development services in the field of nucleic acid and protein therapeutics and diagnostics; Biotechnology research services, namely, nucleic acid and protein therapeutics development for applications in the lung, pediatric, gastrointestinal, reproductive, kidney, metabolic, infectious disease, cancer, immunological, and genetic disciplines; Medical and scientific research and development services in the field of nucleic acid and protein therapeutics and diagnostics; Research and development of medicines; Pharmaceutical research and development services in the field of nucleic acid and protein therapeutics.

Biological preparations, namely, nucleic acids, proteins, and peptides for medical and veterinary purposes; Chemical and biological diagnostic preparations and substances, namely, nucleic acids, proteins and polypeptides, small molecules for medical or veterinary purposes in clinical and medical laboratory use in drug discovery and nucleic acid and protein therapeutics in the bio-pharmaceutical industry; Nucleic acid-protein conjugates for medical or veterinary purposes; Nucleic acids for medical purposes; Nucleic acid therapeutic pharmaceuticals for the treatment of extra-hepatic disease; nucleic acid and protein therapeutics, namely, proteins designed to deliver highly targeted therapeutic modulation for patients suffering from a variety of diseases, namely, autoimmune and inflammatory diseases, metabolic diseases, cancer, chronic kidney diseases, rare diseases, genetic diseases, respiratory diseases, and infectious diseases; Pharmaceutical preparations, namely, nucleic acid and protein therapeutics for the treatment of a variety of diseases, namely, autoimmune and inflammatory diseases, metabolic diseases, cancer, chronic kidney diseases, rare diseases, genetic diseases, respiratory diseases, and infectious diseases; Pharmaceuticals using protein biotherapeutics to treat a variety of diseases, namely, autoimmune and inflammatory diseases, metabolic diseases, cancer, chronic kidney diseases, rare diseases, genetic diseases, respiratory diseases, and infectious diseases; Pharmaceutical preparations containing nucleic acid and protein therapeutics for the treatment of immune system, infectious disease, pulmonary diseases and disorders, genetic diseases, metabolic diseases, kidney diseases, reproductive disorders, gastrointestinal diseases, cancers, and obesity; Protein therapeutic pharmaceuticals for the treatment of human conditions, namely a variety of diseases, namely, autoimmune and inflammatory diseases, metabolic diseases, cancer, chronic kidney diseases, rare diseases, genetic diseases, respiratory diseases, and infectious diseases.